연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2431. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study
Kwon W, Kim H, Han Y, Hwang YJ, Kim SG, Kwon HJ, Vinuela E, Járufe N, Roa JC, Han IW, Heo JS, Choi SH, Choi DW, Ahn KS, Kang KJ, Lee W, Jeong CY, Hong SC, Troncoso AT, Losada HM, Han SS, Park SJ, Kim SW, Yanagimoto H, Endo I, Kubota K, Wakai T, Ajiki T, Adsay NV, Jang JY
Br J Surg
. 2020 Sep;107(10):1334-1343.
Link
2430. Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
Kim H, Kang KN, Shin YS, Byun Y, Han Y, Kwon W, Kim CW, Jang JY
Cancers (Basel). 2020 Jun; 12(6): 1443.
Link
2429. Robotic extended cholecystectomy in gallbladder cancer
Byun Y, Choi YJ, Kang JS, Han Y, Kim H, Kwon W, Jang JY
Surgical Endoscopy (2020) 34:3256–3261
Link
2428. Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy
Kim HS, Kim H, Kwon W, Han Y, Byun Y, Kang JS, Choi YJ, Jang JY
Surg Endosc
. 2020 Apr 10.
Link
2427. Early outcomes of robotic extended cholecystectomy for the treatment of gallbladder cancer
Byun Y, Choi YJ, Kang JS, Han Y, Kim H, Kwon W, Jang JY
J Hepatobiliary Pancreat Sci. 2020;27:324–330.
Link
2426. Central Pancreatectomy Versus Distal Pancreatectomy and Pancreaticoduodenectomy for Benign and Low-Grade Malignant Neoplasms: A Retrospective and Propensity Score-Matched Study with Long-Term Functional Outcomes and Pancreas Volumetry
Lee DH, Han Y, Byun Y, Kim H, Kwon W, Jang JY
Ann Surg Oncol (2020) 27:1215–1224
Link
2425. Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX
Choi YJ, Byun Y, Kang JS, Kim HS, Han Y, Kim H, Kwon W, Oh D-Y, Paik WH, Lee SH, Ryu JK, Kim Y-T, Lee K, Kim H, Chie EK, Jang JY
Gut Liver
. 2020 Aug 26. doi: 10.5009/gnl20070.
Link
2424. Clinicoradiological features of resected serous cystic neoplasms according to morphological subtype and preoperative tentative diagnosis: can radiological characteristics distinguish serous cystic neoplasms from 0other lesions
Kang JS, Kim HJ, Choi YJ, Byun Y, Lee JM, Han Y, Kim H, Kwon Y, Jang JY
Ann Surg Treat Res. 2020 May;98(5):247-253.
Link
2423. Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis
Seock-Ah Im 1 , Binghe Xu 2 , Wei Li 3 , Mark Robson 4 , Quchang Ouyang 5 , Dah-Cherng Yeh 6 , Hiroji Iwata 7 , Yeon Hee Park 8 , Joo Hyuk Sohn 9 , Ling-Ming Tseng 10 , Carsten Goessl 11 , Wenting Wu 11 , Norikazu Masuda 12
Sci Rep
. 2020 May 29;10(1):8753.
Link
2422. Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer
Dong-Hyeon Ha 1 , Ahrum Min 1 2 , Seongyeong Kim 1 , Hyemin Jang 1 2 , So Hyeon Kim 1 , Hee-Jun Kim 1 2 3 , Han Suk Ryu 4 , Ja-Lok Ku 1 , Kyung-Hun Lee 1 2 5 6 , Seock-Ah Im 7 8 9 10
Sci Rep
. 2020 Jun 18;10(1):9930.
Link